Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Finished Goods (2018 - 2023)

SANUWAVE Health has reported Finished Goods over the past 6 years, most recently at $416000.0 for Q4 2023.

  • Quarterly Finished Goods fell 27.02% to $416000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $416000.0 through Dec 2023, down 27.02% year-over-year, with the annual reading at $416000.0 for FY2023, 27.02% down from the prior year.
  • Finished Goods was $416000.0 for Q4 2023 at SANUWAVE Health, down from $570000.0 in the prior quarter.
  • Over five years, Finished Goods peaked at $2.3 million in Q3 2020 and troughed at $343000.0 in Q4 2021.
  • The 5-year median for Finished Goods is $1.2 million (2021), against an average of $1.4 million.
  • Year-over-year, Finished Goods surged 220.77% in 2020 and then plummeted 70.07% in 2021.
  • A 5-year view of Finished Goods shows it stood at $357265.0 in 2019, then surged by 220.77% to $1.1 million in 2020, then plummeted by 70.07% to $343000.0 in 2021, then soared by 66.18% to $570000.0 in 2022, then fell by 27.02% to $416000.0 in 2023.
  • Per Business Quant, the three most recent readings for SNWV's Finished Goods are $416000.0 (Q4 2023), $570000.0 (Q4 2022), and $343000.0 (Q4 2021).